Category: usatoday

  • Embody Updates Consumer Information on Compounded GLP-1 Telehealth Program

    By Flamors media

    WILMINGTON, Del., November 5, 2026 — Embody has published updated consumer information on its compounded GLP-1 telehealth program, outlining prescription eligibility, pricing, and safety considerations.

    Embody, the telehealth weight management platform operated by Modern Metabolic Medicine, Inc., has published updated consumer information describing its compounded GLP-1 program, including its clinician-review process, pharmacy arrangements, treatment options and customer terms.

    One of the important distinctions consumers need to understand is that compounded medications are not the same as FDA-approved medicines,” said John S., Media Relations Manager at Embody. “We believe information about the prescribing process, pharmacy preparation, medication-specific instructions and payment terms should be clearly available so individuals can discuss their options and questions with a qualified healthcare professional.

    Embody is not a medical provider. Independent licensed clinicians affiliated with medical groups determine whether a prescription is medically appropriate. Completing an online intake or selecting a treatment preference does not guarantee approval.

    Program Structure and Clinical Review

    According to the company’s published materials, Embody’s program offers access to compounded semaglutide and compounded tirzepatide, subject to an independent clinician’s assessment. Both are described as once-weekly injectable medications. The clinician determines the medication, starting dose and any subsequent dose adjustments based on the patient’s individual circumstances.

    The process begins with an online health questionnaire covering medical history, current medications and weight-management goals. The company states that payment is collected when a plan is selected, before the clinical review is complete. If a clinician approves treatment, the prescription is sent to a partner compounding pharmacy for preparation and shipment. If treatment is not approved, the company’s terms describe a refund of the unused portion, less services already provided.

    The company identifies Red Rock Compounding Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx among its pharmacy partners. The specific pharmacy preparing an individual prescription should be confirmed with the care team.

    Compounded Medication Is Not FDA-Approved

    The program’s published information emphasizes that compounded semaglutide and tirzepatide are not FDA-approved products. Compounded drugs are prepared by pharmacies for individual prescriptions and do not undergo the FDA’s premarket review for safety, effectiveness and quality that applies to approved medicines. Findings from clinical trials of FDA-approved products should not be assumed to establish the safety or effectiveness of a compounded preparation.

    The distinction is relevant when consumers compare online GLP-1 programs. They should establish whether a service provides compounded medication, an FDA-approved medicine, or both, and should ask the prescribing clinician or dispensing pharmacy about the specific formulation.

    For injectable compounded products, the concentration in a vial and the corresponding syringe measurement matter. Patients should obtain written instructions for the prescribed dose and must not independently convert units, change a dose or use instructions from a different formulation.

    Safety Information and Patient Considerations

    GLP-1 medicines can cause side effects, including nausea, vomiting, diarrhea, constipation and abdominal discomfort. Serious risks described in FDA-approved product labeling include pancreatitis, gallbladder problems, dehydration-related kidney complications and low blood sugar in some patients using certain diabetes medicines. Product labeling for approved semaglutide and tirzepatide medicines also contains a boxed warning concerning thyroid C-cell tumors observed in rodents.

    These warnings do not establish that a compounded preparation has been evaluated in the same way as an FDA-approved product. Patients should discuss personal risk factors, other medications and treatment alternatives with a qualified healthcare professional.

    People with a history of pancreatitis, gallbladder or kidney disease, certain thyroid cancer risks, or those who are pregnant, planning pregnancy or breastfeeding should raise those circumstances before treatment. The program is described as intended for adults aged 18 and older and is not available in every state.

    Billing, Renewal and Cancellation Terms

    Embody’s terms describe plans with monthly, three-month, six-month and 12-month durations. The company states that its program is cash-pay and does not accept health insurance; it reports accepting HSA and FSA cards, subject to the customer’s account rules.

    Plans renew automatically unless cancelled. Billing occurs in four-week cycles, rather than calendar months. The company states that customers must submit cancellation requests through the account portal or customer support at least 72 hours before the next billing date to stop the next scheduled charge. Customers should retain written confirmation.

    The published refund terms state that payments, including prepaid plans, are generally final and non-refundable. The stated exception is when a clinician determines that a customer is medically ineligible; in that circumstance, the company says the unused portion is refunded after deducting services already provided.

    Medication that has been dispensed cannot be returned. The terms also describe an arbitration provision and a 30-day period to opt out by mailed written notice.

    Information for Consumers Researching Embody GLP-1

    Consumers reviewing Embody GLP-1 information should compare the full plan commitment rather than relying only on a monthly starting figure. They should also confirm the medication formulation, the prescribing clinician’s role, the dispensing pharmacy, the renewal date, the cancellation deadline and the refund conditions before paying.

    The company says its program operates in selected U.S. states. State availability and individual medical eligibility are determined during the intake and clinical review process. Shipping is handled by third parties, and delivery timelines are not guaranteed under the company’s terms.

    The updated information is available through Embody’s official website at https://healthydialogues.org/ Consumers should use the company’s official channels to verify program details and customer support contacts.

    About Embody

    Embody is a U.S. telehealth weight management platform operated by Modern Metabolic Medicine, Inc., 1811 Silverside Road, Wilmington, Delaware. The platform coordinates an online intake process through which independent licensed clinicians may assess individuals for treatment involving compounded semaglutide or compounded tirzepatide. When prescribed, medications are prepared and shipped by partner compounding pharmacies. Embody does not independently practice medicine or manufacture the medications.

    Media Contact

    John S., Media Relations Manager at Embody
    1811 Silverside Road, Wilmington, Delaware, USA
    Email: support@joinem.co
    Phone: (347) 269-4270

  • Modafinia Announces Modafinia.org as Its Only Official Website

    Modafinia Announces Modafinia.org as Its Only Official Website

    Modafinia has announced Modafinia.org as its only official website address, providing an important clarification for visitors, existing customers and people searching for the brand online. The announcement is intended to establish a consistent digital identity and help reduce confusion surrounding similar domain names.

    Finding the correct website is not always straightforward. People often discover businesses through Google searches, social media posts, online articles, saved bookmarks, and links shared by other users. When several domain names contain the same brand name, it can become difficult to know which one represents the organization.

    To address this issue, Modafinia is directing visitors to Modafinia.org as its designated official website. The announcement also clarifies that Modafinia.com is not the official website identified by the brand. Visitors are encouraged to check the complete website address before relying on information, accessing accounts or sharing personal details online.

    Modafinia.org: The Only Official Website Address

    According to Modafinia’s announcement, Modafinia.org is the brand’s only official website address. The domain is intended to serve as the central online reference for people looking for information associated with Modafinia.

    Having one official website address makes it easier for visitors to find the right place when looking for a brand online. It also helps avoid confusion when checking the latest updates, announcements, or customer information.

    Sometimes, older website links continue to appear in Google search results, online articles, or saved bookmarks, even after a brand starts using a different domain. This can leave visitors unsure about which website they should visit.

    That’s why it’s always a good idea to check the full website address before clicking a link or sharing personal information. Modafinia has clearly identified Modafinia.org as its only official website, and visitors should use this address when looking for the brand online responsibility.

    Important Notice: Modafinia.com Is Not the Official Website, Modafinia.com is a fake website

    Alongside the announcement, Modafinia has clarified the difference between Modafinia.org and Modafinia.com. Modafinia.com is not the official website designated by the brand, it’s a fake website. The announcement asks visitors not to confuse this domain with Modafinia’s stated official online platform. Modafinia.com has been impersonating or redirecting to scam customers online.

    The safest approach is to verify the complete web address independently. A similar name or appearance does not, by itself, establish that two websites are operated by the same organisation.

    Modafinia’s announcement is intended to make this distinction clear: the brand identifies Modafinia.org as its only official website. Visitors who encounter other domains using a similar name should not assume that those websites are affiliated with Modafinia.

    Important Website Notice: Modafinia.org Is the Only Official Website

    Modafinia has confirmed that Modafinia.org is its only official website. Modafinia.com is not authorised or operated by the brand and is a fake site impersonating or redirecting to scam users. Existing customers can visit Modafinia.org and login to check their previous order history. The brand also states that an email about this website update was sent on 7 September. Please verify the website address before logging in or sharing personal information. Modafinia is responsible for services provided through its designated official website only.

    Important Note: Use Modafinia.org Only

    Modafinia has confirmed that Modafinia.org is its only official website. Modafinia.com is not operated or authorized by the brand. Existing customers can visit Modafinia.org to check their previous order history.

    Please make sure you are visiting the correct website before placing an order or making a payment. Modafinia states that it cannot take responsibility for orders, payment disputes or fraud-related issues arising from transactions made through unauthorized websites. Always verify the complete website address and check the relevant licensing and regulatory information before purchasing medicines online.

    Additional Published Source for the Official Website Announcement

    Readers looking for another published reference to the website announcement can find a related publication on MacDailyNews.

    Published Source: Modafinia Announces Modafinia.org as Its Only Official Website – MacDailyNews

    The publication discusses Modafinia’s announcement concerning its designated website address and the distinction between similar domain names. It provides an additional reference for readers who want to review the announcement outside the brand’s own website.

    This publication should be understood as a related announcement reference, rather than independent verification of website ownership, business operations or regulatory status.

    Official Website: https://modafinia.org/

    Why Official Website Verification Matters

    Checking a website address is a simple but important part of responsible internet use. People regularly share information online, sign in to accounts and communicate with businesses through websites. If a visitor reaches a domain that only resembles the address they intended to visit, there may be uncertainty about who operates that website and how submitted information will be handled.

    This is why website verification should never be based on appearance alone. A professional design, familiar logo or matching brand name is not sufficient evidence that a website is officially connected to a business.

    Visitors should check the spelling of the domain, review the website’s contact information and look for consistent references from sources they can independently verify. They should also be cautious with unexpected emails, messages or links that request passwords, payment details or other sensitive information.

    For websites relating to medicines or online pharmacy services, additional checks are necessary. Visitors should independently verify the operator’s identity, relevant licensing and regulatory information, and the legal requirements that apply in their location. A website announcement or domain name alone does not establish that a pharmacy or medicine supply service is legitimate, authorised or safe.

    Information for Existing Modafinia Customers

    The website announcement is also relevant to people who have previously interacted with Modafinia and may have saved an older website address.

    Over time, customers can accumulate bookmarks, email links and browser history entries that point to different domains. These saved references may continue to appear even when a business communicates a new or updated official address.

    Modafinia is asking existing visitors to recognise Modafinia.org as its designated official website. Anyone checking previous account or order information should first confirm the website address and use contact details obtained through independently verified channels.

    It is also important not to assume that an account, order record or customer service conversation on a similarly named website is connected to Modafinia. If there is uncertainty about an account or an earlier order, visitors should seek clarification through a verified contact channel rather than submitting personal information to an unfamiliar website.

    Keeping browser bookmarks and saved links current can help prevent accidental visits to outdated or unrelated domains.

    100% Money-Back Guarantee: Refund and Reshipment Policy

    Modafinia has also highlighted a 100% Money-Back Guarantee relating to orders that are not delivered to the USA, UK and Australia (AU) as usual, according to the policy information provided in its announcement.

    The stated policy addresses situations in which an order does not reach the intended destination. It refers to refund and reshipment options as part of the brand’s delivery-related customer policy.

    For customers, clear information about delivery problems and available remedies is important. Before relying on a refund or reshipment commitment, visitors should read the complete policy and understand the conditions that apply. These may include eligibility requirements, delivery confirmation procedures, the process for reporting a non-delivered order and any applicable exclusions.

    Customers should refer to the latest policy published through the brand-designated website Modafinia.org for the exact terms. The announcement’s summary should not be treated as a replacement for the full policy or as a guarantee that every individual situation will qualify.

    Clear and accessible policy information helps visitors understand what a business says it offers and what steps may be required if a delivery issue occurs.

    How to Identify the Correct Modafinia Official Website

    When searching for Modafinia online, visitors should take a moment to confirm the complete website address. Search-result titles, snippets and website graphics can be useful for discovery, but they should not be treated as proof of an official connection.

    A few practical checks can help:

    • Check the complete domain: Confirm that the address is spelled exactly as intended.
    • Use verified references: Compare the website address with announcements and contact information obtained from sources you can independently verify.
    • Be careful with unexpected links: Avoid signing in through unfamiliar emails, messages or advertisements.
    • Review website information: Check the operator’s identity, contact details and relevant policy pages.
    • Verify pharmacy credentials: Where medicines are involved, check the applicable licensing and regulatory requirements independently.

    These steps are useful whenever visitors encounter multiple websites using similar brand names.

    Where to Find the Official Modafinia.org Website

    If you’re looking for Modafinia’s official website, visit modafinia.org. Always check the full website address before opening a link. Don’t assume that another website with a similar name is connected to Modafinia.

    For website-related announcements and policy information, Modafinia identifies this domain as its official online reference. Visitors should still review the information available there carefully and independently confirm any details that are important to them.

    Moving Forward with One Official Website

    Modafinia’s announcement is focused on one central message: Modafinia.org is the only official website address designated by the brand.

    By communicating a single domain, the brand aims to make its online identity easier to recognise and reduce uncertainty for people who encounter similar website addresses. The clarification is particularly relevant to existing visitors who may have saved older links or come across different domain references while searching online.

    Ultimately, checking a website’s full address is a small step that can help people make more informed decisions online. Visitors should verify the source of information, review relevant policies and exercise appropriate caution before sharing personal or payment details.

    For the official website announcement and the brand-designated online destination, Modafinia directs visitors to Modafinia.org.

    About Modafinia

    Modafinia is an online brand that aims to provide visitors with clear information and accessible customer communication. To maintain a consistent online identity, the brand has designated Modafinia.org as its only official website. Visitors can refer to this domain for brand announcements, website updates and published policies. Modafinia encourages everyone to check the complete website address and review relevant information before sharing personal details or making online transactions.

    Customer Support

    For questions about website information, existing orders or published policies, visitors can contact Modafinia through its customer support email:

    Email:  support@modafinia.org

    Visitors should confirm that they are using the correct email address and avoid sharing passwords or sensitive payment information through email.

    Disclaimer

    The information published on this website is provided for general informational purposes and should not be considered medical advice. Information about medicines does not replace consultation with a qualified healthcare professional. Visitors should independently verify the website operator, applicable pharmacy licences and regulatory requirements before making decisions. Modafinia identifies Modafinia.org as its only official website; references to other websites do not imply an affiliation or endorsement.

    Media contact: john@modafinia.org

    Official Website: https://modafinia.org/

  • This is a text article for usatoday

    This is a text article for usatoday